National Institute of Allergy and Infectious Diseases; Notice of Closed Meeting, 72600 [2016-25340]
Download as PDF
<![CDATA[
72600
Federal Register / Vol. 81, No. 203 / Thursday, October 20, 2016 / Notices
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
DEPARTMENT OF HOMELAND
SECURITY
National Institutes of Health
U.S. Customs and Border Protection
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meeting
[CBP Dec. No. 16–18]
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel Pilot Clinical Trials to
Eliminate the Latent HIV Reservoir (U01).
Date: November 17, 2016.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 5601
Fishers Lane, Rockville, MD 20892,
(Telephone Conference Call).
Contact Person: J. Bruce Sundstrom, Ph.D.,
Scientific Review Officer, Scientific Review
Program, Division of Extramural Activities,
Room 3G11A, National Institutes of Health/
NIAID, 5601 Fishers Lane, MSC 9823,
Bethesda, MD 20892–9823, 240–669–5045,
sundstromj@niaid.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
Dated: October 14, 2016.
Natasha M. Copeland,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2016–25340 Filed 10–19–16; 8:45 am]
BILLING CODE 4140–01–P
Electronic Visa Update System (EVUS)
Requirements: Identification of the
People’s Republic of China (PRC) as
an EVUS Country and Designation of
Maximum Validity B–1, B–2, and B–1/
B–2 Visas as Designated Visa
Categories
AGENCY:
U.S. Customs and Border
Protection, Department of Homeland
Security.
ACTION: Notice.
SUMMARY:
In this Federal Register, DHS
is publishing a final rule titled
‘‘Establishment of the Electronic Visa
Update System (EVUS)’’ (hereafter
‘‘EVUS Final Rule’’), amending 8 CFR
part 215, subpart B, to establish the
Electronic Visa Update System and to
specify certain requirements. According
to the rule, nonimmigrant aliens who
hold a passport issued by an identified
country containing a U.S. nonimmigrant
visa of a designated category will be
required to provide biographic and
other information to DHS by enrolling
in EVUS to maintain the validity of
those visas. The EVUS final rule
specifies that the Secretary of Homeland
Security, in consultation with the
Secretary of State, may identify
countries and designate nonimmigrant
visa categories for purposes of the EVUS
requirements and that notice of
identified countries and designated
nonimmigrant visa categories will be
published in the Federal Register.
Through this notice, the Secretary of
Homeland Security, after consultation
with the Secretary of State, identifies
the People’s Republic of China (PRC) as
an EVUS country and designates B–1,
B–2, and B–1/B–2 visas issued without
restriction for the maximum validity
period, which is generally 10 years,1 as
designated visa categories when the
visas are contained in a passport issued
by the PRC.
DATES: This identification and
designation is effective October 20,
2016.
mstockstill on DSK3G9T082PROD with NOTICES
FOR FURTHER INFORMATION CONTACT:
Suzanne Shepherd, Office of Field
Operations, Suzanne.M.Shepherd@
cbp.dhs.gov or (202) 344–2073.
SUPPLEMENTARY INFORMATION:
1 This includes visas issued for more than nine
years and all replacement visas issued to correct
errors in the original instance.
VerDate Sep<11>2014
16:40 Oct 19, 2016
Jkt 241001
PO 00000
Frm 00039
Fmt 4703
Sfmt 4703
Background
In this Federal Register, DHS is
publishing a final rule titled
‘‘Establishment of the Electronic Visa
Update System (EVUS)’’ amending 8
CFR part 215, subpart B, to establish the
Electronic Visa Update System. EVUS is
an online information update system
that allows for the collection of
biographic and other information from
nonimmigrant aliens who hold a
passport issued by an identified country
containing a U.S. nonimmigrant visa of
a designated category. See EVUS Final
Rule. Nonimmigrant aliens subject to
these regulations must periodically
enroll in EVUS and obtain a notification
of compliance prior to travel to the
United States. As discussed in the
Department of State’s parallel rule,
‘‘Visa Information Update Requirements
under the Electronic Visa Update
System (EVUS),’’ also published in this
Federal Register, individuals subject to
the EVUS requirements must comply
with the EVUS regulations in 8 CFR part
215, subpart B, in order to maintain the
validity of their visas of a designated
category.
As specified in 8 CFR 215.22, and
explained in the EVUS Final Rule, the
Secretary of Homeland Security, in the
Secretary’s discretion and in
consultation with the Secretary of State,
may identify countries (‘‘EVUS
countries’’) whose passport holders will
be subject to the EVUS regulations, if
the passport contains a U.S.
nonimmigrant visa of a designated
category, and designate applicable visa
categories. The regulations state that
notice of identified countries and
designated visa categories will be
published in the Federal Register. See
8 CFR 215.22 and 8 CFR 215.23(c). This
announcement provides such a notice.
Identification and Designation
Pursuant to 8 CFR 215.22, the
Secretary, following consultation with
the Secretary of State, identifies the
People’s Republic of China (PRC) as an
EVUS country and designates all B–1,
B–2, and B–1/B–2 visas issued without
restriction for maximum validity, which
generally will be 10 years, but includes
visas issued for more than nine years
and all replacement visas issued to
correct errors in the original visa, as
designated visa categories when the
visas are contained in a passport issued
by the PRC.
B nonimmigrant visas, often referred
to as ‘‘visitor visas,’’ are issued to
individuals seeking to travel and be
admitted to the United States
temporarily for business (visa category
B–1); for tourism or pleasure, (visa
E:\FR\FM\20OCN1.SGM
20OCN1
]]>Agencies
[Federal Register Volume 81, Number 203 (Thursday, October 20, 2016)]
[Notices]
[Page 72600]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-25340]
[[Page 72600]]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and Infectious Diseases; Notice of
Closed Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of the following
meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute of Allergy and Infectious
Diseases Special Emphasis Panel Pilot Clinical Trials to Eliminate
the Latent HIV Reservoir (U01).
Date: November 17, 2016.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 5601 Fishers Lane,
Rockville, MD 20892, (Telephone Conference Call).
Contact Person: J. Bruce Sundstrom, Ph.D., Scientific Review
Officer, Scientific Review Program, Division of Extramural
Activities, Room 3G11A, National Institutes of Health/NIAID, 5601
Fishers Lane, MSC 9823, Bethesda, MD 20892-9823, 240-669-5045,
sundstromj@niaid.nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.855,
Allergy, Immunology, and Transplantation Research; 93.856,
Microbiology and Infectious Diseases Research, National Institutes
of Health, HHS)
Dated: October 14, 2016.
Natasha M. Copeland,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2016-25340 Filed 10-19-16; 8:45 am]
BILLING CODE 4140-01-P
